| 标题 |
The Eatl-001 Trial: Results of a Phase 2 Study of Brentuximab Vedotin and CHP Followed By Consolidation with High-Dose Therapy - Autologous Stem-Cell Transplantation (HDT-ASCT) in the Frontline Treatment of Patients with Enteropathy-Associated T-Cell Lymphoma |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:David Sibon; Sherine Khater; Julie Bruneau; Chantal Brouzes; Ludovic Lhermitte; et al 出版日期:2021-11-24 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)